In the present study, we investigated the plasma concentrations of CXCL1 and CXCL8 in female breast cancer patients as potential tumor markers in the diagnostic process, as an individual or combined parameter with the routinely used marker CA 15-3. Here, CXCL8 is linked to breast cancer.